BLU-U Blue Light Photodynamic Therapy Illuminator (Model 4170E)
Sun Pharmaceutical Industries, Inc. · Decision date Nov 2, 2026
What did the FDA approve?
The FDA recorded an approval decision on 2026-11-02 for P990019/S010, a supplement to the BLU-U® Blue Light Photodynamic Therapy Illuminator (Model 4170E) held by Sun Pharmaceutical Industries, Inc. The device falls under the photodynamic therapy laser system category, with product code MVF and a listed specialty of general and plastic surgery.
The supplement is recorded as a real-time process submission with the stated reason of change to design, components, specifications or material. Its recorded scope is software changes adding error remediation approaches and optimization of software intercommunications. This decision covers that supplement only, not a new approval of the underlying system. The source lists no supporting documents, so the specific software versions, affected components and review basis remain unknown.
FDA approval order statement
approval for software changes adding error remediation approaches and optimization of software intercommunications.
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Nov 2, 2026
- FDA change category
- Change Design/Components/Specifications/Material
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P990019/S010
- Regulatory pathway
- PMA supplement
- Applicant
- Sun Pharmaceutical Industries, Inc.
- Product code
- MVF
- Decision code
- APPR
- Decision date
- Nov 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, laser, photodynamic therapy.
- Applicant
- Sun Pharmaceutical Industries, Inc.
- Product code
- MVF
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P990019. Subsequent supplements may change the device or its indications.
FDA decision timeline
P990019 · Original PMA
BLU -U BLUE LIGHT PHOTODYNAMIC THERAPY ILLUMINATOR
P990019/S010 received
Application receipt date recorded by FDA.
P990019/S010 · FDA decision
Real-Time Process
Timeline entries are records held by MedtechLedger for P990019. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P990019
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Sun Pharmaceutical Industries, Inc. | PMA approval | Dec 3, 1999 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Sun Pharmaceutical Industries, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 29 Dunham Rd., Billerica, MA, 01821
Sources and methodology
- Original FDA record: P990019/S010
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records